<DOC>
	<DOC>NCT00000342</DOC>
	<brief_summary>The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the treatment of cocaine dependence, to evaluate impact of treatment on craving, and to correlate evidence of baseline neurotoxic damage of cocaine with treatment outcome and clinical side-effects.</brief_summary>
	<brief_title>Risperidone for the Treatment of Cocaine Dependence - 7</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>M/F ages 2150. Meet DSMIV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 1997</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>